University Hospital Tuebingen
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Private
- Established
- 1388-01-01
- Employees
- -
- Market Cap
- -
Apixaban for Treatment of Embolic Stroke of Undetermined Source
Phase 3
Completed
- Conditions
- Embolic Stroke of Undetermined Source
- Interventions
- First Posted Date
- 2015-04-27
- Last Posted Date
- 2021-10-13
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 352
- Registration Number
- NCT02427126
- Locations
- 🇩🇪
Regiomed Kliniken Coburg GmbH Abt. II, Coburg, Germany
🇩🇪Neurologie, Klinikum Friedrichshafen GmbH, Friedrichshafen, Germany
🇩🇪Carl von Basedow KlinikumSaalekreis gGmbH, Merseburg, Germany
FLuorescence Identification of Melanoma by a Multicenter Based Algorithm (FLIMMA)
Completed
- Conditions
- MolesMelanoma
- Interventions
- Device: LIMES
- First Posted Date
- 2015-04-24
- Last Posted Date
- 2017-05-03
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 500
- Registration Number
- NCT02425475
- Locations
- 🇩🇪
Dept. of Dermatology, University Hospital, Tübingen, Germany
🇩🇪Dept. of Dermatology, Charité, Berlin, Germany
Evaluation of Effects of Green Coffee Bean Extract (GCE) on Physiological and Psychological Variables
Not Applicable
Withdrawn
- Conditions
- Blood Pressure
- Interventions
- Dietary Supplement: decaffeinated coffeeDietary Supplement: chlorogenic acidDietary Supplement: green coffee bean extract supplementDietary Supplement: placebo
- First Posted Date
- 2015-03-17
- Last Posted Date
- 2016-01-26
- Lead Sponsor
- University Hospital Tuebingen
- Registration Number
- NCT02388672
Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas
Not Applicable
Completed
- Conditions
- Glioblastoma
- Interventions
- Device: iMRI-guided surgeryDrug: 5-ALA-guided surgery
- First Posted Date
- 2015-03-05
- Last Posted Date
- 2021-10-22
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 315
- Registration Number
- NCT02379572
- Locations
- 🇩🇪
International Neuroscience Institute Hannover, Hannover, Germany, Hannover, Germany
🇩🇪Department of Neurosurgery, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
🇩🇪Department of Neurosurgery, University of Ulm, Hospital Günzburg,, Günzburg, Germany
Efficacy of Cognitive Behavioral to Hypnotherapeutic Treatment of Depression
Not Applicable
Completed
- Conditions
- Major Depressive Disorder
- Interventions
- Behavioral: HDTBehavioral: ACDT
- First Posted Date
- 2015-03-02
- Last Posted Date
- 2018-09-25
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 153
- Registration Number
- NCT02375308
- Locations
- 🇩🇪
Prof. Dr. A. Batra/ Dr. Kristina Fuhr, University Department for Psychiatry and Psychotherapie, Tuebingen, Germany
Fingerprint Characterization of Advanced HCC
Completed
- Conditions
- Carcinoma, Hepatocellular
- Interventions
- Other: Image FingerprintOther: Molecular Fingerprint
- First Posted Date
- 2015-02-26
- Last Posted Date
- 2019-06-19
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 25
- Registration Number
- NCT02372162
- Locations
- 🇩🇪
University Hospital, Tuebingen, BW, Germany
Point-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants 1
Completed
- Conditions
- Anticoagulation With Direct Oral Anticoagulants
- First Posted Date
- 2015-02-25
- Last Posted Date
- 2015-02-26
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 60
- Registration Number
- NCT02371044
Point-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants 2
Completed
- Conditions
- Anticoagulation With Direct Oral Anticoagulants
- First Posted Date
- 2015-02-25
- Last Posted Date
- 2016-07-01
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 60
- Registration Number
- NCT02371070
Preoperative Radiochemotherapy With Hyperthermia for Locally Advanced Rectal Cancer
Phase 2
Completed
- Conditions
- Rectal CancerLocally Advanced Rectal CancerHyperthermiaHyperthermic RadiochemotherapyHyperthermic ChemoradiotherapyDeep Regional Hyperthermia
- Interventions
- Other: Deep regional hyperthermiaRadiation: RadiotherapyDrug: Chemotherapy (5-Fluorouracil)
- First Posted Date
- 2015-02-03
- Last Posted Date
- 2018-02-13
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 78
- Registration Number
- NCT02353858
- Locations
- 🇩🇪
University Hospital Tübingen, Department of Radiation Oncology, Tübingen, Baden-Württemberg, Germany
Hypoxia-based Dose Escalation With Radiochemotherapy in Head and Neck Cancer
Not Applicable
- Conditions
- Squamous Cell Carcinoma of the Head and Neck
- Interventions
- Radiation: radiochemotherapy with 70 GyRadiation: radiochemotherapy with 77 Gy
- First Posted Date
- 2015-02-02
- Last Posted Date
- 2015-02-02
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 90
- Registration Number
- NCT02352792
- Locations
- 🇩🇪
Tuebingen university, radiation oncology, Tuebingen, Baden-Württemberg, Germany
© Copyright 2025. All Rights Reserved by MedPath